- Home
- SSY vs APVO Comparison
SSY vs APVO Comparison
Compare SSY & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- APVO
- Stock Information
- Founded
- SSY 1959
- APVO 2016
- Country
- SSY United States
- APVO United States
- Employees
- SSY N/A
- APVO N/A
- Industry
- SSY Hospital/Nursing Management
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- APVO Health Care
- Exchange
- SSY Nasdaq
- APVO Nasdaq
- Market Cap
- SSY 5.5M
- APVO 5.4M
- IPO Year
- SSY N/A
- APVO N/A
- Fundamental
- Price
- SSY $1.00
- APVO $1.38
- Analyst Decision
- SSY
- APVO Strong Buy
- Analyst Count
- SSY 0
- APVO 1
- Target Price
- SSY N/A
- APVO $296.00
- AVG Volume (30 Days)
- SSY 32.0K
- APVO 1.2M
- Earning Date
- SSY 05-14-2025
- APVO 05-07-2025
- Dividend Yield
- SSY N/A
- APVO N/A
- EPS Growth
- SSY N/A
- APVO N/A
- EPS
- SSY 0.14
- APVO N/A
- Revenue
- SSY $31,233,000.00
- APVO N/A
- Revenue This Year
- SSY N/A
- APVO N/A
- Revenue Next Year
- SSY N/A
- APVO N/A
- P/E Ratio
- SSY $7.25
- APVO N/A
- Revenue Growth
- SSY N/A
- APVO N/A
- 52 Week Low
- SSY $0.53
- APVO $0.94
- 52 Week High
- SSY $1.91
- APVO $180.19
- Technical
- Relative Strength Index (RSI)
- SSY 50.27
- APVO 31.11
- Support Level
- SSY $0.97
- APVO $0.94
- Resistance Level
- SSY $1.09
- APVO $2.64
- Average True Range (ATR)
- SSY 0.08
- APVO 0.45
- MACD
- SSY -0.00
- APVO -0.07
- Stochastic Oscillator
- SSY 61.54
- APVO 16.42
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.